The age-dependent decline in immune function, known as immunosenescence, severely restricts an organism's ability to defend itself against infectious agents, leading to an enhanced susceptibility to pathogens later in life. In humans and other vertebrate species, the most distinctive features of immunosenescence are those that affect adaptive immunity, and T cells in particular. Aging is accompanied by involution of the thymus, and the T cell pool comes to be dominated by memory cells, leaving relatively little space to be occupied by naïve cells that provide protection from newly encountered pathogens ([@bib25]). Immunosenescence is also characterized by a weakened innate immune response, as revealed by studies of individual types of leukocytes. For example, neutrophils from older animals exhibit reduced chemotaxis ([@bib10]). In addition, older dendritic cells have a diminished capacity to phagocytose and present antigens, thus reducing T cell priming ([@bib14]). While many of the hallmarks of immunosenescence have been described, less is understood about potential age-dependent changes at the molecular level in the underlying regulatory pathways that govern host defense. Since cross-talk between pathways facilitating communication between multiple cell types adds to the complexity of this problem, studies to address it at a more fundamental level have benefited from experimental systems such as worms and flies that lack the confounding effects of a bipartite immune system.

Invertebrates retain several components of innate immunity, demonstrating that key elements of immune protection are evolutionarily conserved. Circulating hemocytes with the ability to either sequester, engulf, or poison pathogens are part of the defense arsenal of coelomate metazoans, including the fruitfly, *Drosophila melanogaster* (reviewed in Melillo *et al.* 2018). Other invertebrates, such as the roundworm *Caenorhabditis elegans*, lack true circulating immune cells and instead have an even simpler, more ancient immune system. While the means by which worms detect and distinguish between microbes is still unclear, exposure to pathogens triggers a humoral response involving the production of antimicrobial peptides (AMPs) ([@bib17]). AMPs are predicted to be secreted by intestinal epithelial cells in a manner that is reminiscent of mucosal immunity in other species. The expression of AMPs and other proteins important for responding to acute infection in *C. elegans* is regulated by three evolutionarily conserved signaling pathways: the TGF-β pathway ([@bib91]), the [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) p38 MAPK pathway ([@bib40]), and the insulin signaling pathway ([@bib28]), each of which has been shown to modulate the function of immune cells in mammals ([@bib30]; [@bib24]; [@bib4]).

Over the last 20 years, several studies have shown that, similar to vertebrates, the ability of flies and worms to resist infection diminishes with age, with older animals dying from acute infection more rapidly than young animals ([@bib81]; [@bib47]; [@bib71]; [@bib89]). This suggests that the factors responsible for eroding and reshaping immunity over time may be shared among animals that experience aging, regardless of the complexity of their means of host defense. As it has been described thus far, immunosenescence in *C. elegans* seems to be brought on by three age-related changes that directly infringe upon the expression of AMPs. The first is a collapse in proteostasis beginning in early adulthood ([@bib6]; [@bib83]) that is coupled with accumulation of vitellogenin in the intestine ([@bib33]; [@bib74]). Experimental conditions to mimic these conditions using transgenic animals caused them to be more susceptible to *P. aeruginosa* infection, and mutations in [VIT-2](https://identifiers.org/bioentitylink/WB:WBGene00006926?doi=10.1534/g3.120.401166) that cause it to build up in the intestine block the expression of genes encoding immune effectors. This leads to a model in which the protein instability later in life triggers the repression of genes encoding secreted proteins including those that function in immunity, yet whether this scenario plays out during normal aging has not been directly tested ([@bib76]). A second contributor to immunosenescence in *C. elegans* is a decline in the activity of the [SKN-1](https://identifiers.org/bioentitylink/WB:WBGene00004804?doi=10.1534/g3.120.401166) transcription factor over time ([@bib70]). In addition to its well-characterized role in oxidative stress resistance ([@bib2]) [SKN-1](https://identifiers.org/bioentitylink/WB:WBGene00004804?doi=10.1534/g3.120.401166) is also required for resistance to *P. aeruginosa* infection in both larvae and adults. A third factor in the age-dependent decline in immunity in *C. elegans* is a progressive decrease in the levels of the [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) protein during aging that enhances the susceptibility of older animals to bacterial infection ([@bib89]). Without youthful levels of [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166), the worm is left with one less branch of its innate immune system as the expression levels of genes encoding immune effectors regulated by the [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)/p38 MAPK pathway decrease. Whether the activity of the two other major pathways that modulate immunity in *C. elegans* also declines over time is not known. Considering its vital roles in both stress resistance and lifespan determination, we hypothesized that the insulin signaling pathway plays an important role in protecting older worms from infection.

Across evolutionarily diverse animal phyla, the insulin and insulin-like growth factor signaling pathway (IIS) plays the dual role of regulating lifespan and integrating environmental cues to regulate growth and development ([@bib38]; [@bib80]; [@bib43]; [@bib82]; [@bib90]). Two of the key components of the IIS pathway are a transmembrane receptor for insulin/insulin-like ligands and a transcription factor of the Forkhead Box family (FOXO) whose transcriptional activity is regulated by a cascade of kinase-mediated phosphorylation reactions ([@bib46]). In the default status of this pathway when the insulin receptor is bound by a ligand, the ensuing phosphorylation cascade culminates in an inhibitory phosphate group being added to the FOXO transcription factor, preventing its translocation to the nucleus to regulate the expression of its target genes. This inhibition may be overcome, however, when an animal encounters an acute stress. For example, in *C. elegans* under circumstances of starvation, irradiation, or other insults, the FOXO transcription factor is de-repressed and upregulates the expression of genes important for neutralizing the stress or counteracting its effects ([@bib32]; [@bib22]). Manipulations to artificially activate the FOXO transcription factor (for example, by overexpressing FOXO or disrupting the function of the insulin receptor) dramatically extend the worm's lifespan. Such experiments suggest that variability in the degree of FOXO activity during aging could help to explain how some individuals live longer and in better health than others. Indeed, in synchronized aging cohorts of *Caenorhabditis elegans*, animal-to-animal differences in FOXO activity have been observed, with greater levels of activity positively correlating with longer lifespan ([@bib73]).

In *C. elegans* [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is the ortholog of mammalian FOXO3a, and its transcriptional activity is antagonized by the IIS when the [DAF-2](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) receptor is occupied by insulin-like peptides. Much of what is understood about the function of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) has been revealed through studies of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutants in which the constitutive activation of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) more than doubles the worms' lifespan ([@bib38]). One of the key elements that underlies the extended lifespan of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutants is their remarkable resilience when challenged with environmental insults. [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutants are resistant to an astounding array of stressors including hypoxia ([@bib36]), anoxia ([@bib26]), oxidative stress, thermal stress, and ultraviolet light ([@bib66]; [@bib88]) as well as fungal and bacterial pathogens ([@bib28]; [@bib88]; [@bib39]). In each case the enhanced resistance of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) animals, as demonstrated by their ability to outlive wild type animals subjected to the same stressors, is completely dependent upon [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), implying that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) modulates the transcriptional response to environmental stress. Supporting this possibility, when animals are exposed to stressful conditions, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) translocates from the cytosol to the nucleus. For example, in both L2 larvae and in mature adult *C. elegans*, the oxidative stress- inducing compound juglone results in nuclear accumulation of DAF-16::GFP ([@bib32]). Starvation, heat, and ultraviolet irradiation are other stimuli that drive DAF-16::GFP into the nucleus in *C. elegans* ([@bib59]; [@bib32]; [@bib56]; [@bib23]; [@bib77]; [@bib64]). This phenomenon is evolutionarily conserved, as oxidative stress also induces the nuclear translocation of FOXO3 and FOXO4 in mammalian cells ([@bib11]; [@bib44]). Multiple transcriptomic studies using a variety of platforms have demonstrated that once inside the nucleus, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) upregulates genes whose products function to directly neutralize environmental threats or to repair the damage caused by them ([@bib62]; [@bib50]; [@bib67]; [@bib84]; [@bib12]; [@bib55]). These include antimicrobial peptides, superoxide dismutases, and chaperones. The basis for the long life of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutants, therefore, appears to lie at least in part in the enhanced expression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional targets that buffer animals against environmental perturbations and that maintain cellular health.

As [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is the foremost contributor to stress resistance in [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) animals, it would stand to reason that, in a corresponding manner, [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) mutants themselves would exhibit sensitivity to the same stresses to which [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutants are resistant. For the most part, this is indeed the case. When [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) function is compromised by either loss-of-function mutations or by RNAi, animals die more rapidly than wild type controls when subjected to hypoxic conditions ([@bib36]), paraquat and hydrogen peroxide ([@bib69]), high temperature ([@bib54]), and heavy metals ([@bib15]; [@bib54]). However, in the absence of systemic [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), larval stage worms do not seem to be more susceptible to infection by opportunistic human pathogenic bacteria ([@bib28]; [@bib56]; [@bib23]) or fungi ([@bib39]). These observations suggest that although it is important for the defense against other stresses, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) does not protect younger animals from infection. Curiously, when *C. elegans* are infected as Day 2 adults after transitioning from the L4 stage to reproductive maturity in the presence of RNAi targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) they then succumb to infection with *Pseudomonas aeruginosa* more rapidly than untreated control animals ([@bib86]). This raises the intriguing possibility of an age-dependent role for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in innate immunity, but a systematic analysis of the function of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during aging to has not yet been performed.

We wondered whether the erosion of PMK-1-mediated immunity during aging may be counterbalanced by the function of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166). To test this possibility, we took a primarily genetic approach to functionally characterize [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) over time, with a particular emphasis on examining its role in post-reproductive adults. During aging in wild type animals maintained under standard (non-stressed) laboratory conditions the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) increases in an age-dependent manner, beginning in early adulthood. Analysis of genome-wide changes in expression during aging revealed that in adult *C. elegans* some [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets are upregulated while others are downregulated, suggesting that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) acts as both a transcriptional activator and a repressor in those animals. An important functional consequence of activating [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during aging is immune protection, and we find that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) functions specifically during adulthood to protect aging animals from bacterial infection. In its role in innate immunity [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) appears to cooperate with [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166), a regulatory component of the protein phosphatase 4 (PP4) complex. Our data thus establish that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is functional during normal healthy aging in wild type animals. Further, they imply that the activation of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in adults may be part of an age-dependent compensatory mechanism to preserve organismal health in response to the flagging activity of other stress response pathways.

Materials and Methods {#s1}
=====================

C. elegans strains and maintenance {#s2}
----------------------------------

Worms were maintained using standard techniques as previously described ([@bib9]). The *C. elegans* strains used in this study are as follows: Bristol wildtype N2, KU25 \[[*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*)*\], GR1329 \[[*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)*\], [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*);*[*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574?doi=10.1534/g3.120.401166)*)*, DR1572 \[[*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1368*](https://identifiers.org/bioentitylink/WB:WBVar00143947?doi=10.1534/g3.120.401166)*)*\], CB1370 \[[*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)*\], TJ356 [*zIs356*](https://identifiers.org/bioentitylink/WB:WBTransgene00005218?doi=10.1534/g3.120.401166) \[*daf-16p*::*daf-16a/b*::*GFP +*[*rol-6*](https://identifiers.org/bioentitylink/WB:WBGene00004397?doi=10.1534/g3.120.401166)*(*[*su1006*](https://identifiers.org/bioentitylink/WB:WBVar00248869?doi=10.1534/g3.120.401166)*)*\], CF1407 \[[*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mu86*](https://identifiers.org/bioentitylink/WB:WBVar00089216?doi=10.1534/g3.120.401166)*)*;[*muIs71*](https://identifiers.org/bioentitylink/WB:WBTransgene00001050?doi=10.1534/g3.120.401166) \[(*pKL99*) *daf-16ap::GFP::daf-16a*(*bKO*)) + *rol6*([*su1006*](https://identifiers.org/bioentitylink/WB:WBVar00248869?doi=10.1534/g3.120.401166))\]\], *HT1889* \[[*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf50*](https://identifiers.org/bioentitylink/WB:WBVar00088974?doi=10.1534/g3.120.401166)*)*;[*unc-119*](https://identifiers.org/bioentitylink/WB:WBGene00006843?doi=10.1534/g3.120.401166)(*ed3*)*;lpIs14* \[*daf-16f::GFP* + [*unc-119*](https://identifiers.org/bioentitylink/WB:WBGene00006843?doi=10.1534/g3.120.401166)*(+)*\]\], *RX87* \[[*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)*;[*xrls87*](https://identifiers.org/bioentitylink/WB:WBTransgene00005108?doi=10.1534/g3.120.401166) \[*daf-16a::GFP::DAF-16b* [*rol-6*](https://identifiers.org/bioentitylink/WB:WBGene00004397?doi=10.1534/g3.120.401166)*(*[*su1006*](https://identifiers.org/bioentitylink/WB:WBVar00248869?doi=10.1534/g3.120.401166)*)*\]\], and VIL001 *[mjyls1](http://identifiers.org/bioentitylink/WB:WBTransgene00026646?doi=10.1534/g3.120.401166)* *\[plys-7*::*GFP\]*.

To generate strain VIL001, stable transgenic animals harboring an extrachromosomal [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) promoter::gfp fusion construct ([@bib1]) were subjected to gamma irradiation to yield a chromosomal integration of *plys-7*::*gfp*. F~2~ segregants of the irradiated P~0~ animals yielding 100% GFP-expressing progeny were selected for further analysis. One of these lines was backcrossed to the N2 wildtype strain seven times and then designated VIL001.

Generation of age-matched cohorts of C. elegans {#s3}
-----------------------------------------------

Synchronized populations of worms were obtained by sodium hypochlorite treatment of gravid adult animals to harvest eggs followed by hatching L1 larvae in M9 buffer without nutritional supplementation for 16-20h at 22°. Approximately 2000 L1 larvae were plated on to NGM media seeded with either *E. coli* OP50 *or E. coli* HT115 strains harboring RNAi constructs, depending on the experiment. To age animals to the sixth day of adulthood, worms were allowed to develop to the L4 larval stage before transferring them to new NGM plates containing 25 µg/mL 5-fluorodeoxyuridine (FUdR) and seeded with *E. coli*.

RNAi treatment {#s4}
--------------

*E. coli* HT115 strains carrying plasmids encoding dsRNA were thawed from glycerol stocks stored at -80° and grown overnight at 37° on LB plates supplemented with ampicillin and tetracycline. Single colonies were used to inoculate 200 mL of LB + ampicillin and incubated with shaking overnight at 37°. To concentrate cells, cultures were centrifuged for 10 min at 3000x*g* and the cell pellet was resuspended in 25 mL of fresh LB supplemented with ampicillin. Approximately 1 mL of the concentrated cell cultures was used to seed two sets of NGM plates: one containing 100 µg/mL carbenicillin, and 2 mM IPTG (referred to as "RNAi plates") and a second set containing 100 µg/mL carbenicillin, 2 mM IPTG, and 25 µg/mL FUdR; referred to as "RNAi + FUdR plates"). Seeded plates were incubated in the dark at 22° for at least 3 days before animals were added to them for knockdown experiments.

Synchronized populations of worms were subjected to RNAi treatments at one of two points during aging, depending on the experiment. For experiments involving a brief pulse of RNAi to knockdown [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), L1 larvae harvested from hypochlorite treatment of gravid adult hermaphrodites were maintained on NGM plates with *E. coli* OP50 as the food source at 20° as described above until the fourth day of adulthood. At 48 hr prior to initiating infection with *P. aeruginosa*, these adult animals were transferred to RNAi +FUdR plates seeded with the [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) RNAi clone (or L4440 vector control clones) and incubated at 20°. For all other RNAi experiments, after hatching overnight in M9 buffer L1 larvae harvested from hypochlorite treatment of gravid adult hermaphrodites were introduced to concentrated *E. coli* RNAi clones seeded on to RNAi plates and maintained on those plates at 20°. Once these animals reached the L4 stage, they were transferred by chunking to RNAi + FUdR plates where they were allowed to move away from the agar chunk before it was removed from the plate. Worms were aged on these plates at 20° until the sixth day of adulthood when they were harvested or used for other assays.

Fluorescence microscopy {#s5}
-----------------------

To monitor the expression of *Plys-7*::*GFP* during aging, worms on RNAi or RNAi + FUdR plates were inspected under a fluorescence dissecting microscope (Zeiss) equipped with a Zeiss digital camera. Over 200 animals were examined per condition per time point and a subset of animals was imaged in each of two replicates. To generate micrographs documenting the expression of the *plys-7*::*GFP* reporter or of DAF-16::GFP during aging, *C. elegans* maintained on NGM plates seeded with OP50 or subjected to feeding-based RNAi were mounted onto agarose pads (10% agarose in M9 buffer) seated on glass slides and immobilized in a slurry of 0.1 μm polystyrene beads (Polysciences, Warrington, PA). To avoid confounding effects of stress on the localization of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), all worms expressing DAF-16::GFP were imaged within 15 min of being mounted onto slides. Samples were examined by compound fluorescence microscopy on a Nikon E800 microscope and images were captured with a Jenoptik monochrome digital camera. For all imaging studies, camera settings including exposure time were held constant for all samples.

Pseudomonas aeruginosa infection {#s6}
--------------------------------

Infections of larval stage and adult *C. elegans* with *P. aeruginosa* were carried out as described ([@bib89]). Briefly, approximately 100 animals of the indicated ages were transferred from plates containing *E. coli* OP50 or *E. coli* HT115 (for RNAi treatments) to plates seeded with *P. aeruginosa* strain PA14 and incubated at 25°. The survival of worms on the *P. aeruginosa* plates was assessed and dead animals were removed every 12-24 hr until all of the worms in the assay had died. Each assay was replicated at least twice.

Calculation of median survival times and statistical analysis {#s7}
-------------------------------------------------------------

To calculate the median survival time (LT~50~) of *C. elegans* infected with *P. aeruginosa*, the fraction of animals alive at each time point during an assay was first plotted as a function of time in Excel, accounting for animals that were inadvertently overlooked or that escaped between time points. These data were then imported into SigmaPlot (Systat Software, San Jose, CA) and a three parameter sigmoidal curve was fit according to the general equation y = a/(1+e^(-(x-x0)/b)^). Examples of regression curves applied to our survival data using this method are provided in Fig. S1, and the parameters used are provided in Table S1. This equation was used to determine the point at which 50% of the animals in the assay had died (Efron 1987). The average fold difference between the LT~50~ of mutant strains or experimental RNAi treatments and control animals was calculated, and the statistical significance of that difference was assessed using a one-sample *t*-test after first applying a Shaprio-Wilk test for normality.

RNA isolation {#s8}
-------------

Approximately 5,000-10,000 animals were washed off of NGM plates in M9 buffer and allowed to settle to the bottom of a 15 mL conical tube by gravity. After removing the supernatant the worms were washed with 10 mL of fresh M9 and again allowed to settle to the bottom of the tube. All but 1-2 mL of buffer were removed and used to resuspend the worms before transferring them to cryovials where more buffer was removed, leaving behind sufficient volume to cover the worm pellet. After adding 300 μL of Trizol reagent (ThermoFisher Scientific, Waltham, MA), the worms were vortexed in a series of 30 sec intervals over a period of 5 min interspersed by brief rest periods and then transferred to -80° for storage. To prepare total RNA from worm pellets, frozen animals in Trizol were thawed at room temperature and then briefly vortexed before pelleting in a microcentrifuge at 16,000x*g* for 5 min to remove worm carcasses and debris. Following a phenol/chloroform extraction, total RNA was precipitated in isopropanol, washed in 70% ethanol, and resuspended in RNase-free H~2~O. For RNAseq experiments, total RNA was treated with DNase and reisolated over a column using the RNeasy kit (Qiagen, Germantown, MD). The concentration of RNA was measured by either Nanodrop (ThermoFisher Scientific, Waltham, MA) or by Qubit fluorimetry (Invitrogen, Carlsbad, CA).

mRNAseq analysis {#s9}
----------------

Total RNA harvested from independent biological replicates of N2 L4 (duplicate) or Day 6 adult (triplicate) *C. elegans* fed the RNAi vector control *E. coli* strain HT115. RNA was isolated as described above, and samples from the same replicate were prepared at the same time. Prior to RNAseq analysis, RNA was first scrutinized for evidence of degradation and the presence of robust peaks corresponding to ribosomal RNA (rRNA) using a Bioanalyzer (Agilent Technologies, Santa Clara, CA) and agarose gel electrophoresis. rRNA was then depleted using Ribo-Zero (Illumina, San Diego, CA), and cDNA libraries were prepared by strand-specific cDNA synthesis. After determining the median library insert size and total yield, samples were sequenced using Illumina HiSeq 2500 1x 125 single read technology.

Bioinformatics methods {#s10}
----------------------

Bioinformatic analysis was carried out by iGenBio (Chicago, IL) using proprietary ERGO 2.0 software. Briefly, fastqc sequence files were checked for ribosomal depletion, contamination, leftover adapter sequences, and other issues, and the samples were trimmed. All samples were aligned against the reference genome (Wormbase version WS254) using TopHat2. The alignments were then run with featureCounts obtaining a table of counts for each feature in the reference genome. The counts were then imported into R where a customized version of arrayQualityMetrics was run on the samples. The data were then normalized using edgeR's calcNormFactors and then transformed using limma's voom. Data were analyzed using Igen Bio's proprietary ERGO platform, with differentially expressed genes identified through DESeq2.

Ranked lists of genes differentially expressed between Day 6 adults and L4 larvae were generated with corresponding *p* and *q* values for each gene. To identify genes with statistically significant changes in expression between the L4 larval stage and Day 6 of adulthood, we eliminated from our list of differentially expressed genes any gene that had a *q* value greater than or equal to 0.05. For this study we considered only those genes whose expression changed by fivefold or more. To generate a complete catalog [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional targets, we created a composite list of non-duplicate entries for genes that are either positively- or negatively regulated by [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) reported in three different studies ([@bib84]; [@bib12]; [@bib55]). The catalog was then compared to our filtered comprehensive lists of genes differentially regulated during aging. To visualize genomewide changes in expression during aging, we created a scatter plot of the average number of reads for each gene in L4 samples compared to Day 6 samples. Using those data points as a background, we superimposed plots of only certain subsets of genes, including all [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets from our compiled list in addition to genes identified as age-dependent targets of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) ([@bib55]). Functional information regarding the products of genes differentially regulated during aging or of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional targets was obtained through analysis of gene lists using Gene Ontologies through the Panther database (pantherdb.org) and were focused on GO biological process and child cellular process annotations.

qRT-PCR {#s11}
-------

For analysis of gene expression levels by qRT-PCR, cDNA was reverse transcribed from 1 μg samples of total RNA using Retroscript (ThermoFisher Scientific, Waltham, MA). Diluted cDNA was used as a template in PCR reactions designed to amplify sequences from [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166), [*sod-3*](https://identifiers.org/bioentitylink/WB:WBGene00004932?doi=10.1534/g3.120.401166), and [*mtl-1*](https://identifiers.org/bioentitylink/WB:WBGene00003473?doi=10.1534/g3.120.401166) transcripts with [*tba-1*](https://identifiers.org/bioentitylink/WB:WBGene00006528?doi=10.1534/g3.120.401166) as the reference using primer pairs described previously ([@bib85]). Sybr Green (Roche, New York, NY) was used to detect the products of the PCR reactions, and fluorescence was quantified using an Eppendorf Master Cycler (Eppendorf, Hauppauge, NY). Relative gene expression levels were calculated using the ΔΔCt method ([@bib60]). This analysis was performed on a total of three biological replicates, representing three independently generated cohorts of aging worms (Table S2).

Data availability {#s12}
-----------------

RNAseq data are available on the GEO database (ncbi.nlm.nih/geo) under accession number GSE146443. Files uploaded as supplemental material to figshare are described below. Figure S1 shows curves fit to experimental survival data shown in Figure 2 using the logarithmic regression analysis described above. Figure S2 shows a second replicate of the *P. aeruginosa* infection assay involving [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) animals (Figure 4). It also shows survival curves of animals treated with RNAi targeting [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) and then infected with *P. aeruginosa* at the L4 larval stage and Day 6 of adulthood. Figure S3 shows the results of a second replicate of the experiment investigating the function of individual isoforms of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) (Figure 6). Figure S4 depicts *Plys-7*::*GFP* expression in L4 animals treated with RNAi targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) or [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166). Figure S5 depicts *Plys-7*::*GFP* expression in Day 3 adult animals treated with RNAi targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) or [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166). Figure S6 depicts *Plys-7*::*GFP* expression in Day 6 adults treated with RNAi targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) or [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166).

Table S1 lists parameters used in the equation to generate the curves to fit survival data shown in Figure 2 and Figure S1. Table S2 contains raw qRT-PCR data on which the normalized expression levels of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional targets in Figure 7 are based. Table S3 lists experimental details and statistical analyses corresponding to each survival curve in Figures 1-4, 6, and 8. Table S4 lists genomewide changes in expression between the L4 larval stage and Day 6 of adulthood. Tables S5 and S6 list overrepresented GO biological process terms associated with genes up- and downregulated at Day 6, respectively. Table S7 is a catalog of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets made by compiling lists of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets identified in previous reports ([@bib84]; [@bib12]; [@bib55]). Table S8 lists [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) target genes that are differentially expressed between the L4 larval stage and Day 6 of adulthood. Tables S9 and S10 list overrepresented GO biological process terms associated with [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets that are up- and downregulated at Day 6, respectively. Supplemental material available at figshare: <https://doi.org/10.25387/g3.11964351>.

Results {#s13}
=======

Comparison of PMK-1 and DAF-16 function in innate immunity {#s14}
----------------------------------------------------------

Although they are members of distinct genetic pathways and regulate separate groups of genes, both [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) and [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) are necessary for lifespan extension of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* mutants, suggesting that there may be some degree of functional overlap between the two gene products ([@bib85]). [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) and [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) also confer enhanced resistance to pathogens in larval stage [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* animals, indicating that each may contribute to longevity through at least partially redundant functions in innate immunity. Whether the two proteins operate in a similar manner in the context of aging in wild type animals is not known. To compare the functions of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) and [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) in innate immunity during aging, we examined the survival of [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*)*, [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* and [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*);*[*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants upon infection with the human opportunistic bacterial pathogen *Pseudomonas aeruginosa* at the fourth larval stage (L4) and at Day 6 of adulthood (D6; six days after the transition to L4). Consistent with previous reports, when bacterial infection was initiated at the L4 larval stage, [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*)* mutants died more rapidly from the infection than did wild type animals, confirming a role for [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) in the innate immunity of juvenile *C. elegans* ([Figure 1A](#fig1){ref-type="fig"}). The [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* loss-of-function mutation, on the other hand, did not affect the ability of L4 worms to resist bacterial infection. In addition, [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* did not further enhance the susceptibility of animals bearing a lesion in the [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) locus, as [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*);*[*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* double mutants died from infection at the same rate as [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*)* mutants ([Figure 1A](#fig1){ref-type="fig"}). These data suggest that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) plays little to no role in innate immunity in L4 larvae and that host defense is mediated for the most part by [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) at that stage. When infection was initiated at Day 6 of adulthood we observed a different pattern in the survival of the mutants ([Figure 1B](#fig1){ref-type="fig"}). While [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*)* mutants still died faster from the infection than wild type animals, the median lifespan of infected [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants was also reduced. In addition, the [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*);*[*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* double mutant displayed an additive phenotype, with the shortest median lifespan of all the strains. These results suggest that by Day 6 of adulthood a second arm of innate immunity mediated by [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) has become activated and that it functions in parallel to [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166).

![[DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) likely functions in parallel to [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) to modulate innate immunity during aging. (A) Survival of wild type strain N2 (blue), and mutant strains [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* (orange), [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*)* (pink), and [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*);*[*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*)* (turquoise) transferred from *E. coli* OP50 to *P. aeruginosa* PA14 at L4. (B) Survival of the same strains as in (A) upon initiating infection with *P. aeruginosa* at Day 6 of adulthood. In both panels, the fraction of animals alive is plotted as a function of time. Data are representative of multiple independent replicates.](1521f1){#fig1}

Systematic functional analysis of DAF-16 in innate immunity during aging {#s15}
------------------------------------------------------------------------

To systematically address the potential role for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in innate immunity in adult *C. elegans*, we asked about its functional requirement in host defense over time by challenging [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* animals with *P. aeruginosa* infection at six different points during their lifespan---at the L4 larval stage, on each of the first three days of adulthood when egg-laying is at a peak level, and twice during the postreproductive period (Days 6 and 9 of adulthood). In parallel, age-matched populations of wild type N2 animals were also exposed to pathogen, and their survival was compared to that of the infected [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants. While the absence of functional [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) had little to no effect on the ability of L4 animals or Day 1 adults to resist infection ([Figure 2A, B](#fig2){ref-type="fig"}), the age-dependent increase in susceptibility to bacterial pathogens observed in wild type worms was exacerbated in [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants. This was evident as early as Day 2 of adulthood ([Figure 2C](#fig2){ref-type="fig"}), although the difference in median lifespan (LT~50~) between wildtype animals and [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants was not statistically significant until Day 3 of adulthood ([Figure 2D](#fig2){ref-type="fig"}; Table S3). Day 3 adult N2 worms were no more susceptible to bacterial infection than wild type L4 larvae. However, the average median survival time of Day 3 [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* was 1.4-fold less than the LT~50~ of wildtype control animals (*P* \< 0.001, Table S3). This difference in survival was more pronounced when animals were challenged with *P. aeruginosa* at Day 6 of adulthood ([Figure 2E](#fig2){ref-type="fig"}). The conditions used in our studies successfully recapitulated previous reports of declining immunity in adult worms, manifested as increased susceptibility to bacterial infection over time ([@bib47]; [@bib89]). The absence of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) caused Day 6 adults to die even more rapidly from infection. The median survival time of Day 6 [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* worms challenged with *P. aeruginosa* was less than half of the LT~50~ of N2 wildtype animals (*P* = 0.013, Table S3). The loss-of-function mutation in [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) still had an effect when Day 9 adults were infected with *P. aeruginosa*, resulting in a nearly twofold reduction in LT~50~ of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants as compared to control worms (*P* = 0.003, [Figure 2F](#fig2){ref-type="fig"}, Table S3). Our observations suggest that despite playing only a minor role, if any, in innate immunity in larval stage *C. elegans*, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) becomes increasingly important for host defense during aging.

![[DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) functions in innate immunity in adult but not larval *C. elegans*. (A-F) Wild type strain N2 (blue) or [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* (orange) mutants were maintained on *E. coli* OP50 and then challenged with *P. aeruginosa* PA14 at the L4 larval stage (A) or at the indicated day of adulthood (B-F). In each case, the fraction of animals alive is plotted as a function of time. Data are representative of multiple independent replicates.](1521f2){#fig2}

Timing requirement for DAF-16 in adult innate immunity {#s16}
------------------------------------------------------

Since loss of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is associated with precocious early aging or "progeric" phenotypes ([@bib72]) our observation that adult [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants are more susceptible to bacterial infection than larval stage [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* animals raises the possibility that instead of playing a direct role in immunity during adulthood, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is required throughout the entirety of the worm's life to protect against premature frailty that would cause adult animals to be especially vulnerable to attack by pathogens. To investigate whether this is true, we asked whether a short pulse of RNAi to knock down [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) just before challenging Day 6 adult worms with *P. aeruginosa* would affect their ability to resist the infection to the same extent as a sustained RNAi regimen targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) from the L1 larval phase up until the time that the infection was initiated at the sixth day of adulthood. We reasoned that if [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) contributes to innate immunity in adult animals by principally functioning during adulthood, then waiting until Day 4 of adulthood to inhibit [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) expression should be sufficient to cause enhanced susceptibility to pathogen upon infecting RNAi-treated worms with *P. aeruginosa* at Day 6. On the other hand, if [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) somehow exerts its effect on immunity by acting earlier in life then it should be necessary to begin knocking down [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) while worms are still developing to affect their ability to resist bacterial infections as adults. Similar to the phenotypes of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants, animals treated with RNAi targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) beginning at the L1 larval stage were no more susceptible to bacterial infection than untreated controls when challenged at L4 ([Figure 3A](#fig3){ref-type="fig"}), but they died more rapidly than control animals when infected at Day 6 ([Figure 3B](#fig3){ref-type="fig"}). A brief pulse of RNAi targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) at Day 4 had the same effect on the pathogen susceptibility of Day 6 adults as knocking down [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) beginning at the first larval stage ([Figure 3C](#fig3){ref-type="fig"}). Our data indicate that DAF-16-mediated immunity in adult animals is a consequence of the specific function of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during adulthood and not before. This agrees with previous observations indicating that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is dispensable in larvae for its role in lifespan determination ([@bib18]).

![[DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) confers resistance to bacterial pathogens during adulthood. (A-C) RNAi was used to test the timing requirement of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in innate immunity. After initiating knockdown of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) by feeding-based RNAi (orange) at the L1 larval stage (A and B) or at Day 4 of adulthood (C), worms were infected with *P. aeruginosa* PA14 as L4 larvae (A) or at Day 6 of adulthood (B and C). L4440 (blue) is an empty RNAi vector control. In each case, the fraction of animals alive is plotted as a function of time. Data are representative of multiple independent replicates.](1521f3){#fig3}

Pathogen resistance phenotype of larval and adult daf-2 mutants {#s17}
---------------------------------------------------------------

While in younger *C. elegans* [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is typically inhibited unless and until animals encounter an environmental insult, we found that as wildtype worms age [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) becomes activated even in the absence of an acute stress. One possible mechanism by which [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) becomes activated in adult *C. elegans* is the age-dependent loss of an inhibitory signal through the IIS pathway. We reasoned that if this were the case, then eliminating this inhibition through a loss-of-function mutation in [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) should shift the period in which worms are protected by DAF-16-mediated immunity to begin immediately upon hatching instead of beginning during adulthood. Moreover, we predicted that if derepression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is sufficient to instigate its immune function then the degree of pathogen resistance conferred by disrupting the insulin receptor should be invariant over the worm's lifespan such that upon infection [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) L4 animals and older post-reproductive [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) worms would experience an equivalent survival advantage relative to their wildtype counterparts. To test our hypothesis, we challenged [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* and [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1368*](https://identifiers.org/bioentitylink/WB:WBVar00143947?doi=10.1534/g3.120.401166)*)* mutants with *P. aeruginosa* at the L4 stage of larval development and at Days 3 and 6 of adulthood. In an allele-specific manner, mutations in [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) conferred varying degrees of resistance to L4 larvae ([Figure 4A](#fig4){ref-type="fig"}). Specifically, while a mutation affecting the ligand-binding domain of [DAF-2](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) ([*e1368*](https://identifiers.org/bioentitylink/WB:WBVar00143947?doi=10.1534/g3.120.401166)) did not affect the survival of infected L4 animals, a mutation in the kinase domain ([*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)) increased maximum survival. Interestingly, we found that the [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) resistance phenotype does not fully manifest until worms become adults. When the *P. aeruginosa* infection was initiated at L4, the survival trajectory of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* mutants paralleled that of wild type worms until ∼96 hr post-infection when their rate of death slowed, causing the median lifespans for all three genotypes in the assay to be similar to each other even though the maximum lifespan of infected [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* animals was extended. We found that the resistance phenotype associated with [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutations becomes more pronounced in adult animals. When infected at D3 of adulthood the [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1368*](https://identifiers.org/bioentitylink/WB:WBVar00143947?doi=10.1534/g3.120.401166)*)* mutants that had lacked a phenotype at L4 became resistant to bacterial infection, with longer median and maximum lifespans in the presence of pathogen than wild type animals ([Figure 4B](#fig4){ref-type="fig"}). The [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* mutation conferred even greater protection from infection, on average more than tripling the LT~50~ of D3 adults as compared to wild type (Table S3). The survival advantage conferred to infected *C. elegans* by mutations in [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) persisted at Day 6 of adulthood when wild type animals showed clear signs of immunosenescence ([Figure 4C](#fig4){ref-type="fig"}). Corroborating the results of our studies of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutants, RNAi targeting [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) caused Day 6 animals to be more resistant to *P. aeruginosa* infection, but it did not affect the susceptibility of L4 worms (Fig. S2). That inactivation of [DAF-2](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) can extend the lifespan of adult animals infected with a bacterial pathogen suggests that relief of an inhibitory signal through the IIS pathway may be important for activating [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during adulthood. Yet the fact that the resistance phenotype of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutants can be modified by age raises the possibility that additional factors present in adult worms could also be required for DAF-16-mediated immunity.

![Aging enhances the resistance to bacterial pathogens conferred by constitutive activation or overexpression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166). (A-C) Wild type N2 worms (blue), [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1368*](https://identifiers.org/bioentitylink/WB:WBVar00143947?doi=10.1534/g3.120.401166)*)* (turquoise), and [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* (purple) worms were infected with *P. aeruginosa* at the L4 larval stage (A) or at Day 3 (B) or Day 6 (C) of adulthood. (D,E) The indicated transgenic strains expressing DAF-16::GFP either in a wildtype (TJ356; purple) or [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) mutant genetic background (HT1889, pink; CF1407, orange; RX87, turquoise) were challenged with *P. aeruginosa* as L4 larvae (D) or as Day 6 adults (E) and their survival after infection was compared to age-matched infected wildtype N2 control animals (blue). The fraction of animals alive *vs.* time is plotted in each panel. Data are representative of multiple independent replicates.](1521f4){#fig4}

In further support of our findings with [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutant animals, we found that overexpression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) did not confer a survival advantage to *C. elegans* that were infected at the L4 larval stage. We tested the ability of four transgenic worm strains that all express DAF-16::GFP to resist *P. aeruginosa* infection at the L4 stage and at Day 6 of adulthood. Three of the strains that we studied (CF1407, HT1889, and RX87) overexpress different isoforms of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) that each complement a [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) loss-of-function mutation, and one overexpresses a *daf-16a/b* isoform in a wildtype background (TJ356). Increased expression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) at the L4 larval stage was not sufficient to confer resistance to *C. elegans* infected with *P. aeruginosa* ([Figure 4D](#fig4){ref-type="fig"}), yet it substantially improved the survival of worms infected with bacteria at Day 6 of adulthood compared to wildtype controls ([Figure 4E](#fig4){ref-type="fig"}). This parallels the phenotype of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants that exhibit enhanced susceptibility to pathogen only during adulthood ([Figure 2](#fig2){ref-type="fig"}). Moreover, it substantiates the idea of a time-dependent component to the implementation of DAF-16-mediated immunity, even if absolute levels of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) itself are in excess.

Expression pattern and subcellular localization of DAF-16 during aging {#s18}
----------------------------------------------------------------------

Collectively, the results of our functional analyses raise the possibility of a discrete transition during early adulthood at which point [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activity is triggered. Since in its inactive state [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), like other FOXO transcription factors, is sequestered in the cytosol, instigating [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activity would necessarily involve its translocation into the nucleus. We predicted that as compared with its subcellular localization in younger *C. elegans*, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in adult animals should be found mostly in nuclei. Although there are previous reports of the subcellular localization of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in adult worms, the techniques used vary widely, and none of the prior studies examined animals under the exact conditions as are standard in our experiments ([@bib5]; [@bib29]; [@bib55]). We anticipated that in examining DAF-16::GFP-expressing animals at Day 6 of adulthood we might observe a pattern of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) localization that is reminiscent of the iconic leopard-spot pattern associated with the induced activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in response to environmental insults ([@bib32]).

We asked whether aging alone or aging coupled with bacterial infection might cause a redistribution of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) from the cytosol to the nucleus. To answer this question we used fluorescence microscopy to monitor the subcellular localization of DAF-16::GFP in CF1407 and TJ356 animals during aging and after challenge with *P. aeruginosa*. CF1407 worms express a DAF-16a::GFP fusion protein and TJ356 animals express a DAF-16a/b::GFP fusion protein. In L4 larval stage CF1407 animals, DAF-16::GFP was most commonly found diffusely distributed throughout the cytosol of intestinal cells ([Figure 5A](#fig5){ref-type="fig"}), although occasionally [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) could be found in the nuclei of intestinal cells and head neurons ([Figure 5B,C](#fig5){ref-type="fig"}). This was surprising considering that our data indicate that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is not active at this stage of life in non-stressed *C. elegans*. Expression of DAF-16::GFP was much more robust in L4 larval stage TJ356 animals, and appeared to be uniformly expressed throughout the cytosol in several cell types, including the intestine ([Figure 5D-F](#fig5){ref-type="fig"}). We did not observe a dramatic accumulation of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) within the nuclei of animals of either strain at Day 6 of adulthood. While overall the worms were somewhat brighter, indicating increased expression of DAF-16::GFP, the majority of it still seemed to be localized to the cytosol ([Figure 5G](#fig5){ref-type="fig"}) This was most evident in intestinal cells where a dark spot presumably corresponding to the nucleus was surrounded by intense GFP signal ([Figure 5 H, J](#fig5){ref-type="fig"}). In other worms, we could detect DAF-16::GFP in the nuclei of head neurons ([Figure 5I](#fig5){ref-type="fig"}), and this expression pattern became more prevalent in adult TJ356 animals than it had been at the L4 larval stage ([Figure 5L](#fig5){ref-type="fig"}). TJ356 adults also expressed DAF-16::GFP in the in the nuclei of other cells in the head, most likely hypodermal cells ([Figure 5K](#fig5){ref-type="fig"}). Exposing Day 6 adults to *P. aeruginosa* for 24 hr did not change the pattern of DAF-16::GFP expression from what was observed in uninfected animals ([Figure 5M](#fig5){ref-type="fig"} compared to [Figure 5G](#fig5){ref-type="fig"}). In intestinal cells of infected animals [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) was found in either the cytosol ([Figure 5N](#fig5){ref-type="fig"}) or the nucleus ([Figure 5Q](#fig5){ref-type="fig"}), and it was still found in the nuclei of head neurons in animals of both strains ([Figure 5 O, P, R](#fig5){ref-type="fig"}) as it had been in uninfected animals and even some L4 larvae. Our data indicate that in adult animals [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is expressed in the intestine and neurons, which may be two important sites of action for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during aging. However, our observations do not indicate a massive translocation of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) to the nucleus during adulthood.

![A fraction of DAF-16a localizes to the nucleus of several tissue types regardless of animals' age or the presence or absence of bacterial pathogens. The expression pattern and subcellular localization of DAF-16::GFP was assessed in two transgenic strains by fluorescence microscopy in L4 larvae (A-F) and Day 6 adults (G-L) grown on *E. coli* or in adults infected with *P. aeruginosa* strain PA14 at Day 6 (M-R). Strain CF1407 expresses a GFP::DAF-16a in a [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mu86*](https://identifiers.org/bioentitylink/WB:WBVar00089216?doi=10.1534/g3.120.401166)*)* mutant background (upper panels) and strain TJ356 expresses DAF-16a/b::GFP in a wildtype background (lower panels). Yellow arrowheads indicate nuclear localization of DAF-16::GFP; blue arrowheads indicate an absence of nuclear localized DAF-16::GFP surrounded by DAF-16::GFP in the cytosol. Images in panels C, I, O, L and R were taken at 400x magnification; all others were at 200x.](1521f5){#fig5}

Functional analysis of specific isoforms of daf-16 in adult C. elegans {#s19}
----------------------------------------------------------------------

There are twelve different isoforms of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), but only a few have been functionally characterized. The two that appear to be especially relevant for stress resistance and aging are *daf-16a* and *daf-16d/f*, but there is a lack of consensus regarding which specific isoform is in fact the predominant lifespan determinant ([@bib45]; [@bib3]; [@bib12]). Both isoforms are upregulated during aging after the L4 stage with a much more dramatic increase in expression of *daf-16d/f* as compared to *daf-16a* ([@bib3]). The timing of the increase in *daf-16a* and *daf-16d/f* expression generally corresponds to the period when our data indicate that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) becomes activated during aging. Also, we observed DAF-16a::GFP in the nuclei of several tissue types in Day 6 adult animals ([Figure 5](#fig5){ref-type="fig"}). Therefore, we asked whether *daf-16a* or *daf-16d/f* contributes to innate immunity in adult animals. For the sake of completeness, we also included the *daf-16b* isoform as part of our analysis, even though it has been implicated to play only minor roles in dauer formation and longevity ([@bib49]; [@bib45]).

To determine whether a specific isoform of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is responsible for mediating innate immunity in adult *C. elegans*, a series of RNAi constructs created by the Tissenbaum lab ([@bib45]) was used to target individual [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms (*a*, *b*, and *d/f*) or combinations of isoforms (*af*, and *abf*) in age-matched cohorts of wild type N2 worms beginning at the L1 stage and continuing until they were challenged with *P. aeruginosa* as L4 larvae or as Day 6 adults. The survival of infected worms was compared to that of an isogenic age-matched control group that had been subjected to RNAi designed to reduce the expression of all [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms (referred to as "*daf-16* total"). Regardless of which isoforms were targeted, RNAi knockdown of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) expression did not affect the resistance of L4 larvae to the bacterial pathogen ([Figure 6A](#fig6){ref-type="fig"}). When the infection was initiated at Day 6, however, all RNAi treatments had at least some impact on the worms' survival. Similar to what was observed in other experiments, knockdown of all [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms by [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) total RNAi reduced the LT50 of Day 6 adults by more than twofold (*P* \< 0.00391, [Figure 6B and C](#fig6){ref-type="fig"}, Table S3). Knocking down the *d/f* isoform of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) did not cause a statistically significant reduction in the LT50 of Day 6 animals, but RNAi targeting *daf-16b* did (Table S3). Notably, only those RNAi treatments that included knockdown of the *daf-16a* isoform were sufficient to recapitulate the susceptibility phenotype produced by the [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) total construct. RNAi targeting the *daf-16a* isoform alone or in combination with the *f* isoform or with both *daf-16b* and *daf-16f* together resulted in a reduction in the LT~50~ of *P. aeruginosa*-infected Day 6 animals that approximated what was observed when the expression of all [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms was inhibited by RNAi ([Figure 6B and C](#fig6){ref-type="fig"}, Fig. S3, Table S3). These results suggest that multiple [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms may contribute to host defense in older animals, with *daf-16a* playing a primary role in modulating innate immunity during adulthood in *C. elegans*.

![Multiple [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms contribute to innate immunity in adult *C. elegans*. (A) L4 larvae or (B) Day 6 adults were infected with *P. aeruginosa* PA14 after being treated with RNAi targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms individually or in combination beginning at the L1 larval stage. L4440 (blue) is an empty RNAi vector control and [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) total (orange) is an RNAi treatment that knocks down all [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms. Separate RNAi constructs were used to knockdown the following isoforms: *daf-16a* (pink); *daf-16d/f* (purple); *daf-16a*, *b*, and *f* (black); *daf-16b* (turquoise); *daf-16a* and *f* (green). In both panels, the fraction of animals alive is plotted as a function of time. (C) A portion of the survival curve in (B), enlarged to illustrate the effect of knocking down different [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms. The color scheme is the same as in panels (A) and (B). Data are representative of multiple independent replicates.](1521f6){#fig6}

Transcriptional activity of DAF-16 during aging {#s20}
-----------------------------------------------

Considering the homology of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) to FOXO transcription factors in other species and its well-established function as a transcriptional regulator in *C. elegans*, any influence that it has on innate immunity must be a consequence of the changes in gene expression that it controls. To conduct our own analysis of the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during aging, we began by first using RNAseq to examine the changes in gene expression that occur between the L4 larval stage and Day 6 of adulthood in wild type N2 animals under the growth conditions that we use during aging experiments in our laboratory to functionally characterize candidate genes. While the expression of most genes changes only modestly between these two time points, we found 1441 genes to be upregulated by greater than fivefold and 2660 genes to be downregulated by greater than fivefold ([Figure 7A](#fig7){ref-type="fig"}, Table S4, q \< 0.05). Among the upregulated genes were those whose products function in the response to cellular stress (including ultraviolet irradiation), DNA repair, telomere maintenance, and ubiquitin-dependent protein catabolic processes (Table S5). Genes downregulated at Day 6 were predominantly associated with metabolic processes, including those that take place in the mitochondria (Table S6).

![[DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional activity during aging is dynamic. (A) Differences in gene expression between the L4 larval stage and Day 6 of adulthood are represented in a scatter plot where the average number of reads corresponding to a particular transcript in Day 6 adults is plotted against the average number of reads corresponding to that same transcript in L4 larvae. Each gene is represented as a single dot where blue dots are the entire genome, and pink squares are all [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets (see methods for a description for how [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets were defined.) Yellow and green triangles are genes reported by Li *et al.* to be up- and downregulated by [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during aging, respectively. Large changes in gene expression between the two time points lie furthest from the principal diagonal. (B) Histogram showing the distribution of fold changes in gene expression between the L4 larval stage and Day 6 of adulthood in the whole genome (blue) and in [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets (pink). Only genes with statistically significant changes (*q* \< 0.05) in expression between L4 and Day 6 were considered. (C) Endogenous transcript levels of the [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) (blue), [*mtl-1*](https://identifiers.org/bioentitylink/WB:WBGene00003473?doi=10.1534/g3.120.401166) (orange) and [*sod-3*](https://identifiers.org/bioentitylink/WB:WBGene00004932?doi=10.1534/g3.120.401166) (pink) were measured by qRT-PCR at the L4 larval stage and at five points during adulthood. Expression levels were normalized to a housekeeping gene, and the fold difference in gene expression at Days 3, 6, 9, 12, and 15 of adulthood relative to L4 expression levels was calculated by the ΔΔCt method. The average fold change in gene expression at each time point is shown. Error bars represent standard deviation of the mean. (D) The expression of the *in vivo* reporter for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activity *Plys-7*::*GFP* was monitored over time by fluorescence microscopy in animals treated with RNAi targeting GFP, [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166), or [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) and compared to control animals treated with an empty RNAi vector, L4440. Shown are representative images of animals at the L4 stage and at Days 3 and 6 of adulthood.](1521f7){#fig7}

To understand what age-related changes in gene expression might be attributable to [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional activity, we created an aggregate catalog of all DAF-16-regulated genes by compiling lists of the transcriptional targets of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) that have been identified previously (Table S7; [@bib62]; [@bib67]; [@bib84]; [@bib12]; [@bib55]). One set of genes included in our catalog was derived from a recent report that identified genes whose dynamic expression over time requires [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) ([@bib55]). We designated these as "DAF-16 aging up" or "DAF-16 aging down" to indicate genes that are temporally up- and downregulated by [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), respectively. When the [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets in our catalog (3909 genes in total) were mapped onto a scatter plot of gene expression levels at Day 6 *vs.* expression levels at the L4 larval stage, we found that the changes in expression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets during this period in large part mirror the differential expression of all genes in the *C. elegans* genome between L4 and Day 6 adults ([Figure 7A](#fig7){ref-type="fig"}). Some [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets were more highly expressed in adult animals while the expression levels of others declined, suggesting that during aging [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) acts as both a transcriptional activator and repressor. Genes identified as being regulated by [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during aging partitioned as expected when mapped onto the scatter plot, with "DAF-16 aging up" genes mostly above the principal diagonal and "DAF-16 aging down" genes mostly below it. Overall, the range of the magnitude of the changes in expression between the L4 larval stage and Day 6 of adulthood was similar between [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets and the genome as a whole ([Figure 7B](#fig7){ref-type="fig"}). At the same time, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) seems to be responsible for some of the most dramatic changes in gene expression that take place between L4 and Day 6 of adulthood. We found 351 [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets to be upregulated by more than fivefold in Day 6 adults (Table S8). Genes encoding products that contribute to the response to stress and DNA replication are overrepresented in this group (Table S9). 676 [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets were detected among genes downregulated by more than fivefold between the L4 larval stage and Day 6 (Table S8). Similar to our analysis of genome-wide changes in expression, the expression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional targets that function in a number of metabolic processes was reduced in post-reproductive adults (Table S10). Surprisingly, 32 genes purported to function in innate immunity were also overrepresented among the [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets that are downregulated in Day 6 animals. In many cases, these genes were assigned to this functional category because they are induced upon exposure to pathogenic bacteria or fungi ([@bib85]; [@bib21]). Only six ([*dct-17*](https://identifiers.org/bioentitylink/WB:WBGene00009431?doi=10.1534/g3.120.401166), [*dod-22*](https://identifiers.org/bioentitylink/WB:WBGene00010125?doi=10.1534/g3.120.401166), [*irg-4*](https://identifiers.org/bioentitylink/WB:WBGene00008584?doi=10.1534/g3.120.401166), [*lys-1*](https://identifiers.org/bioentitylink/WB:WBGene00003090?doi=10.1534/g3.120.401166), [*spp-1*](https://identifiers.org/bioentitylink/WB:WBGene00004986?doi=10.1534/g3.120.401166), and [C55A6.7](https://identifiers.org/bioentitylink/WB:WBGene00008336?doi=10.1534/g3.120.401166)) are reported to result in enhanced susceptibility to pathogens when mutated or targeted by RNAi. Our analysis indicates that as animals age [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) actively modulates the expression of at least a subset of its targets, and stress response genes are included among the targets that are upregulated.

While our RNAseq study indicates that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional activity is elevated in Day 6 adults, we wanted to get a better sense of its behavior over the entire course of the worm's life. Our functional data indicate that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) becomes activated between the first and third days of adulthood and that it remains important for host defense through Day 9 of adulthood ([Figure 2](#fig2){ref-type="fig"}). We wondered whether the timing of an increase in the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) would match our functional analyses, and were curious to know for how long during aging that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) continues to function as a transcriptional regulator. To answer these questions and to validate the RNAseq results, qRT-PCR was used to measure the age-dependent changes in expression of select [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets at the L4 stage and at days 3, 6, 9, 12 and 15 of adulthood ([Figure 7C](#fig7){ref-type="fig"}; Table S2). We focused our studies on [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166), [*sod-3*](https://identifiers.org/bioentitylink/WB:WBGene00004932?doi=10.1534/g3.120.401166), and [*mtl-1*](https://identifiers.org/bioentitylink/WB:WBGene00003473?doi=10.1534/g3.120.401166), three well-established targets of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) with roles in the response to environmental stressors ([@bib67]). Surprisingly, each of these genes exhibited a unique temporal expression pattern. Relative to their levels in L4 larvae, the expression levels of both [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) and [*mtl-1*](https://identifiers.org/bioentitylink/WB:WBGene00003473?doi=10.1534/g3.120.401166) were elevated throughout adulthood, beginning at least as early as Day 3 and continuing until Day 15. The highest expression of [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) occurred at Day 6 of adulthood, gradually declining as worms aged but never dropping to L4 levels of expression. [*mtl-1*](https://identifiers.org/bioentitylink/WB:WBGene00003473?doi=10.1534/g3.120.401166) levels remained relatively constant throughout aging, with little appreciable decline in expression even in the oldest animals tested. The age-dependent expression of [*sod-3*](https://identifiers.org/bioentitylink/WB:WBGene00004932?doi=10.1534/g3.120.401166) followed a completely different pattern. Although there was a small increase in its expression in Day 3 and Day 6 adults, by Day 9 the expression of [*sod-3*](https://identifiers.org/bioentitylink/WB:WBGene00004932?doi=10.1534/g3.120.401166) was slightly less than at L4, and its levels continued to diminish as time went on. Our results indicate that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) becomes activated in early adults and that it continues to remain transcriptionally active throughout aging, even at very late stages of adulthood.

As an additional line of inquiry into the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during aging, we sought to uncover *in vivo* evidence for the age-dependent increase in expression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets using a fluorescent reporter. The most widely used [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) reporter is *sod-3*::*gfp* in which GFP expression is driven by the promoter of [*sod-3*](https://identifiers.org/bioentitylink/WB:WBGene00004932?doi=10.1534/g3.120.401166), a gene that encodes a broadly expressed mitochondrial superoxide dismutase ([@bib58]). Unlike [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) and [*mtl-1*](https://identifiers.org/bioentitylink/WB:WBGene00003473?doi=10.1534/g3.120.401166), we did not identify [*sod-3*](https://identifiers.org/bioentitylink/WB:WBGene00004932?doi=10.1534/g3.120.401166) as a gene that is upregulated during adulthood in our RNAseq study, and by qRT-PCR we detected a progressive decrease in its expression in older worms ([Figure 7C](#fig7){ref-type="fig"}). Accordingly, we were unable to detect an increase in *sod-3*::*gfp* expression during aging by fluorescence microscopy (data not shown). Other *in vivo* sensors of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activity were generated in a previous study describing the specificity of the *C. elegans* innate immune response ([@bib1]). In one of them the promoter of [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) is fused to *gfp*, driving the expression of GFP in intestinal cells. Since [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) was among the genes that we found to be strongly upregulated throughout adulthood, we chose to study the expression pattern of the *Plys-7*::*gfp* reporter over time after first creating a new strain of *C. elegans* (VIL001) where *Plys-7*::*gfp* is chromosomally integrated. Microbial infection induces [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) expression, and [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) is required for resistance to bacterial pathogens, suggesting a direct role for [LYS-7](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) in innate immunity as an antimicrobial factor ([@bib61]; [@bib23]; [@bib68]; [@bib37]; [@bib8]). By homology to the LYS4 gene of the parasite *Entamoeba histolytica*, the product of [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) is predicted to be secreted into the intestinal lumen and to kill bacterial cells through hydrolytic destruction of prokaryotic cell wall peptidoglycans ([@bib53]; [@bib61]). We monitored *Plys-7*::*gfp* expression during aging by fluorescence microscopy in a population of age-synchronized animals maintained under standard laboratory conditions with *E. coli* as the food source ([Figure 7D](#fig7){ref-type="fig"}, L4440). While the expression of the reporter was initially low in L4 larvae, GFP expression increased by Day 3 of adulthood, and it was robustly expressed in Day 6 animals. To confirm that the age-dependent increase in *Plys-7*::*GFP* expression was dependent upon [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), we treated animals with RNAi targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) and, as a control, [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166). Whereas knockdown of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) caused the reporter to be expressed at higher levels than in untreated control animals at all time points (with a rather modest increase in expression at L4), RNAi inhibition of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) suppressed the age-dependent increase in *Plys-7*::*gfp* expression ([Figure 7D](#fig7){ref-type="fig"}; Figs. S4, S5, S6). Knocking down [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) had no influence on the expression of *Plys-7*::*gfp* at any age (Figs. S4, S5, S6). These data indicate that [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) is a target of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in wild type adult animals, and that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is responsible for upregulating [*lys-7*](https://identifiers.org/bioentitylink/WB:WBGene00003096?doi=10.1534/g3.120.401166) during aging. Taken together, our analysis of the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) suggests that during normal aging in unstressed wild type animals a sustained increase in the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) begins during the reproductive phase and persists throughout adulthood. Our observations indicate that during this time, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) modulates the expression of a fraction of its complete repertoire of transcriptional targets, some of which contribute to countering challenges from acute stressors.

Functional analysis of SMK-1 in DAF-16-mediated innate immunity during adulthood {#s21}
--------------------------------------------------------------------------------

Our data implying a role for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in host defense that is restricted to adulthood raises the question of how its activity is regulated as animals age. While the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is controlled in part through phosphorylation by upstream components of the insulin signaling pathway, its function is also regulated by nuclear factors that control the access of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) to its targets and influence its transcriptional output ([@bib65]). Several such factors interact either genetically or physically with [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), yet so far only two, [HSF-1](https://identifiers.org/bioentitylink/WB:WBGene00002004?doi=10.1534/g3.120.401166) and [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166), have been shown to be required for the extended lifespan of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutants ([@bib34]; [@bib72]). Both are also required for normal lifespan of wildtype animals ([@bib27]; [@bib88]; [@bib51]; [@bib13]). [HSF-1](https://identifiers.org/bioentitylink/WB:WBGene00002004?doi=10.1534/g3.120.401166) and [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) may therefore specifically govern the expression of a subset of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets that promote longevity and survival. Indeed, [HSF-1](https://identifiers.org/bioentitylink/WB:WBGene00002004?doi=10.1534/g3.120.401166) appears to predominantly control the expression of genes necessary for the response to thermal stress ([@bib34]). [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166), in comparison, regulates the expression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets that are important for counteracting the effects of different stressors including UV radiation, reactive oxygen species, and bacterial pathogens ([@bib88]). We therefore reasoned that [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) may be the more likely candidate to regulate the function of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in the host defense of adult *C. elegans*.

To investigate the possibility that [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) regulates [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in an age-dependent manner, we first asked whether [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) influences the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in adult worms. RNAi was used to inactivate [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) in a synchronized cohort of worms harboring the *Plys-7*::*GFP* transgene beginning at the L1 larval stage. GFP expression levels were then monitored by fluorescence microscopy at the L4 larval stage and at Day 6 of adulthood ([Figure 8A](#fig8){ref-type="fig"}). Mimicking the effect of knocking down [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), RNAi treatment directed against [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) prevented the age-dependent increase in the expression of the reporter in Day 6 adults. This result suggests that [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) is required for the increase in [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional activity during aging.

![[SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) is required for DAF-16-mediated immunity during adulthood. (A) The expression of the [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) reporter *plys-7*::*GFP* is shown in Day 6 animals that were treated with RNAi targeting the indicated genes beginning at the L1 larval stage. (B) L4 or (C) Day 6 adult N2 wild type *C. elegans* were infected with *P. aeruginosa* PA14 after being treated with RNAi targeting either [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) (orange) or [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) (gray) beginning at the L1 larval stage. L4440 (blue) is an empty RNAi vector control. (D) L4 or (E) Day 6 N2 wild type worms (filled circles) or [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants (denoted by X) were infected with *P. aeruginosa* after initiating RNAi treatment to knock down [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) or [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) at the L1 larval stage. The color scheme indicating the RNAi treatments for N2 animals is as described for panels (B) and (C). For [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) mutants pink is the L4440 vector control, turquoise corresponds to [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) RNAi and purple is [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) RNAi. (F) L4 or (G) Day 6 adult TJ356 animals that overexpress [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) were infected with *P. aeruginosa* after being subjected to RNAi to reduce the expression of either [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) (orange) or [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) (gray) beginning at the L1 larval stage. L4440 (blue) is an empty RNAi vector control. The fraction of animals alive is plotted as a function of time. Data for survival of animals following *P. aeruginosa* infection are representative of multiple independent replicates.](1521f8){#fig8}

We next sought to uncover functional evidence to corroborate the results of our transcriptional reporter analysis. Our hypothesis was that if DAF-16-mediated immunity in adult *C. elegans* is dependent upon [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166), then interventions to disrupt the function of [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) should phenocopy the [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) loss-of-function in bacterial infection assays. We again turned to an RNAi approach to explore this possibility. Beginning at the L1 larval stage, [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) was knocked down in a synchronized population of N2 worms, which were then challenged with *P. aeruginosa* at L4 and at Day 6 of adulthood. In a departure from what we observed when inactivating [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) by RNAi, in L4 larvae [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) knockdown resulted in a small but significant increase in susceptibility to bacterial pathogen (*P* = 0.0342; [Figure 8B](#fig8){ref-type="fig"}; Table S3). Aging exacerbated this phenotype. Similar to the effect of knocking down [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), RNAi targeting [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) shortened the median survival time of Day 6 adult worms infected with *P. aeruginosa* by almost twofold compared to untreated control animals (*P* = 0.00209, [Figure 8C](#fig8){ref-type="fig"}; Table S3). These data are consistent with a role for [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) in innate immunity that, similar to [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), becomes more important during adulthood.

That inhibiting the expression of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) and [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) causes similar phenotypes at Day 6 implies that the two genes act in the same pathway during aging in wild type animals, just as they are reported to do in [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* mutants ([@bib88]). If this is the case, then combining a deficiency in both genes in the same animal should not produce an additive effect. To test this prediction and to further investigate the interaction between [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) and [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during aging, RNAi was used to reduce the expression of [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) in both wild type and [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants. We then compared their survival to untreated control animals upon infection with *P. aeruginosa* at the L4 larval stage and at Day 6 of adulthood ([Figure 8 D, E](#fig8){ref-type="fig"}). Knocking down [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) did not compound the enhanced susceptibility phenotype of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* worms when infected as either L4 larvae or as Day 6 adults. That is, at those ages the survival trajectories of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* mutants treated with RNAi targeting [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) was similar to that of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)*(*[*mgDf47*](https://identifiers.org/bioentitylink/WB:WBVar00275574)*)* control animals and to wild type worms treated with RNAi directed against [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166). These data argue that [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) and [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) function as part of the same genetic pathway during aging in *C. elegans*.

Our functional characterization of [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) during aging indicates that it may be necessary for the increased activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during adulthood that contributes to host defense. If this is the case, we predicted that [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) would be required to bring about any potential benefit that overexpression of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) might confer to infected worms. To test this hypothesis, we used RNAi to knock down the expression of [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) or [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) beginning at the L1 larval stage in *C. elegans* strain TJ356 that expresses DAF-16::GFP ([@bib32]). These animals were then infected with *P. aeruginosa* at either the L4 larval stage or at Day 6 of adulthood. Similar to what we observed in a previous experiment ([Figure 4](#fig4){ref-type="fig"}) we did not observe increased resistance to infection of TJ356 worms at the L4 stage ([Figure 8F](#fig8){ref-type="fig"}). The median lifespan of infected L4 TJ356 animals was comparable to that of wild type worms, and it was unchanged by inhibiting the expression of either [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) or [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166). TJ356 worms grown under feeding-based RNAi conditions did not display the marked resistance to *P. aeruginosa* infection that animals raised on *E. coli* OP50 did ([Figure 8G](#fig8){ref-type="fig"}; compare to [Figure 4E](#fig4){ref-type="fig"}). Instead, control animals maintained an L4-like median lifespan when they were infected with *P. aeruginosa* at Day 6 of adulthood, suggesting that the effect of overexpressing [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) under these growth conditions is to stave off the immunosenescence observed in wild type adults. This bolstered host defense requires [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166). Inhibiting the expression of [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) reduced the median survival of infected Day 6 TJ356 animals, as did knockdown of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) ([Figure 8G](#fig8){ref-type="fig"}; Table S3). This result provides further evidence that [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) contributes to innate immunity specifically during aging, just as [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) does.

Discussion {#s22}
==========

In this study we sought to determine whether in the face of declining [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) activity in adulthood other pathways might emerge as the predominant mediators of host defense in adult *C. elegans*. For the first time, we demonstrate a functional requirement for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in innate immunity specifically during aging. Our functional characterization of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) over time from the L4 larval stage to the ninth day of adulthood suggests that the timing of its contribution to innate immunity is reciprocal to that of [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166). That is, as [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) protein levels fall during aging and therefore minimize its function in immunity, the role of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) becomes more important after the L4 stage, as it is activated once animals transition to reproductive maturity ([Figure 2](#fig2){ref-type="fig"}) ([@bib89]). Our results suggest that the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) increases in an age-dependent manner, even in wild type *C. elegans* maintained under normal conditions in the absence of any environmental stresses ([Figure 7](#fig7){ref-type="fig"}). Both the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) and its role in immunity in adult animals require [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) ([Figure 8](#fig8){ref-type="fig"}), suggesting that, as is the case when it is activated in response to stress in younger worms, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) cooperates with other proteins to carry out its function in adults ([@bib65]). Taken together, the observations we report here indicate that not all pathways that protect animals from infection are in decline during aging. Instead, in adulthood immunity is remodeled such that there may be a shift from one set of immune pathways that combat infection earlier in life to other pathways that take over the duty of host defense later on.

The contribution of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) to lifespan was established in studies demonstrating that it is required for the extended lifespan of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutants ([@bib38]). The critical window for this activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) does not appear to occur during larval development since delaying knockdown of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* mutants until early adulthood is sufficient to completely suppress the [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) longevity phenotype ([@bib18]). Waiting even longer to block the function of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) (until Day 6 or Day 15 of adulthood) by RNAi treatment still partially suppresses [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166), shortening the lifespan of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* to some degree. These experiments demonstrate that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is capable of functioning late into adulthood in *C. elegans*, especially under conditions in which signaling through the IIS pathway is disrupted. Whether [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is normally activated as part of the aging process in wild type animals, however, cannot be discerned from these studies.

Since [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) must translocate from the cytosol to the nucleus to carry out its cellular function as a transcriptional regulator, more direct assessments of the timing of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activation during aging in previous studies have largely relied upon detecting (and often quantifying) the proportion of nuclear-localized [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) over the course of the worm's life, with the caveat that the mere presence of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in the nucleus is not sufficient for its activation ([@bib31]; [@bib7]). Interestingly, even in cases where [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is found to be mostly cytosolic, its transcriptional targets are still expressed ([@bib19]) and physiological processes that are dependent upon [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activation appear to go on as normal ([@bib5]). We encountered a similar phenomenon in studies. Our functional analyses clearly demonstrate an age-dependent role for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in innate immunity even though [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is not completely localized to nuclei across entire synchronized cohorts of adult animals. These observations make evident the need for functional characterization to substantiate conclusions regarding the activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) based on its subcellular localization. Our studies address potential discrepancies between temporal [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) localization and other data by systematically testing the functional requirement for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) over time, and they establish a role for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in innate immunity that is exclusive to adulthood.

Despite indications that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activity may be repressed by fertilized oocytes during reproduction ([@bib63]), a majority of studies of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) localization have found that at least a fraction of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is nuclear early on in reproduction ([@bib59]; [@bib87]; [@bib84]; [@bib5]; [@bib55]), and functional evidence from our study ([Figure 2](#fig2){ref-type="fig"}) and others verifies that it is active at that time ([@bib5]; [@bib55]). There is a lack of consensus among prior studies, however, regarding what happens to [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) later in life in *C. elegans*. Some studies show an efflux of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) out of the nucleus as *C. elegans* age with a corresponding decline in efficiency of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166)-dependent functions that becomes evident at the end of reproduction ([@bib87]; [@bib84]; [@bib5]). Others point to the beginning of the post-reproductive period as the very time when [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) nuclear enrichment is at a maximum ([@bib29]; [@bib55]). This is coincident with the point at which an increase in the expression of the *daf-16a* and *daf-16d/f* isoforms after the L4 stage reaches a peak ([@bib3]). The results of our functional analyses indicate that [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) becomes activated early in adulthood and that it remains active throughout the postreproductive period of life in *C. elegans*.

Our data are consistent with [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) being active at the height of reproduction in hermaphrodite *C. elegans*, as the loss of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) function first results in enhanced susceptibility to bacterial infection at the second day of adulthood ([Figure 2](#fig2){ref-type="fig"}). Consistent with a recent report demonstrating increased expression of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets at Day 2-3 of adulthood ([@bib55]), we were able to narrow the timing of the onset of increased [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activity during aging to Day 2 of adulthood in part because this is the first age at which [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) mutants die faster from bacterial infection than their age-matched wildtype counterparts ([Figure 2C](#fig2){ref-type="fig"}). Around this same time, at Day 3 of adulthood, we detected elevated levels of genes regulated by [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) ([Figure 7C](#fig7){ref-type="fig"}). The expression of some of these genes increased even further as worms aged and remained elevated for more than half of the worm's lifespan, suggesting that there may be a progressive increase in the transcriptional activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) over time. This is likely directed particularly at select genes, as only a subset of the total catalog of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) targets were differentially regulated during aging ([Figure 7A](#fig7){ref-type="fig"}, Table S8). Fine tuning of the transcriptional output of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in adult animals may be achieved at least in part by differences in the relative activity of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms that have been shown to have both discrete and overlapping targets ([@bib12]). Our functional analysis of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) isoforms supports this possibility ([Figure 6](#fig6){ref-type="fig"}). Although multiple isoforms of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) may be expressed and their products activated in adult animals, we uncovered several lines of evidence to suggest that DAF-16a is the predominant active form of the protein in adult animals. First, overexpression of DAF-16a caused Day 6 adult *C. elegans* to become resistant to bacterial infection ([Figure 4E](#fig4){ref-type="fig"}). Second, DAF-16a::GFP could be detected in the nuclei of several different tissue types in Day 6 adult animals ([Figure 5](#fig5){ref-type="fig"}) Third, when specific isoforms of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) were targeted by RNAi, knockdown of *daf-16a* but not *daf-16d/f* resulted in a significant reduction in the survival of Day 6 adults infected with *P. aeruginosa* ([Figure 6B](#fig6){ref-type="fig"}). Future studies to specifically investigate DAF-16a are expected to reveal its direct transcriptional targets in older animals.

While the subset of transcriptional targets of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) that are upregulated during aging encodes products that contribute to a number of different cellular processes (Table S9) we found that there is a discrete functional requirement for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) in innate immunity in adult *C. elegans*. Neither [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) loss-of-function mutants nor animals treated with RNAi targeting [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) were more susceptible to *P. aeruginosa* at the L4 larval stage, but they became more susceptible to the pathogen when infected as adults ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). This is the opposite of the scenario that was previously reported for [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*)* mutants ([@bib89]) and that we recapitulated here where [*pmk-1*](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166)*(*[*km25*](https://identifiers.org/bioentitylink/WB:WBVar00088252?doi=10.1534/g3.120.401166)*)* larvae exhibit a more severe sensitivity to pathogen than adults ([Figure 1](#fig1){ref-type="fig"}). Therefore, whereas [PMK-1](https://identifiers.org/bioentitylink/WB:WBGene00004055?doi=10.1534/g3.120.401166) seems to contribute to innate immunity in larvae and younger adults, in a reciprocal fashion, [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) becomes increasingly important for host defense as animals age. In fact, our data suggest that it is required exclusively during adulthood to confer resistance to bacterial pathogens ([Figure 3](#fig3){ref-type="fig"}), mirroring its timing requirement for lifespan determination ([@bib18]).

The activation of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) during aging does not depend upon an induced response to environmental insults, which in any case appears to wane during adulthood ([@bib19]). Rather, we observed an age-dependent increase in [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activity in the absence of acute stress ([Figure 7C, D](#fig7){ref-type="fig"}). Although the identity of the upstream trigger that stimulates [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) to become activated during aging is not known, one possibility is that the repressive signal through the IIS pathway may be attenuated as animals age. In our hands animals overexpressing [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) died from infection at the same rate as control animals when challenged at the L4 larval stage, but they became resistant to bacterial infection at Day 6 of adulthood ([Figure 4E](#fig4){ref-type="fig"}). If all of the additional copies of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) present in the transgenic animals were immediately activated then the L4 animals should have also been resistant to *P. aeruginosa* infection because they would have been expressing higher levels of immune effectors leading up to their encounter with the pathogen. That the benefit of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) overexpression is delayed until adulthood is consistent with a model in which inhibition of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) via the IIS pathway is counteracted in an age-dependent manner. Accordingly, the pathogen resistance phenotype associated with the two hypomorphic [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) mutations that we studied ([*e1368*](https://identifiers.org/bioentitylink/WB:WBVar00143947?doi=10.1534/g3.120.401166) and [*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)) did not fully manifest until worms reached adulthood ([Figure 4](#fig4){ref-type="fig"}). Putative negative regulation of the IIS pathway with age is likely to occur downstream of the [DAF-2](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166) receptor since the transcript levels of its agonists do not decline over time ([@bib55]).

Regardless of the nature of the upstream input that stimulates [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) activation in adult worms, our data indicate that its age-dependent function requires [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166). [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) is the *C. elegans* ortholog of an evolutionarily conserved regulatory subunit of the phosphoprotein phosphatase 4 (PP4) complex ([@bib42]). In diverse species, the PP4 catalytic subunit forms a trimeric complex with two other proteins that regulate its enzymatic function and determine its substrate specificity ([@bib16]; [@bib78]). Acting to antagonize the function of a host of kinases, the PP4 complex carries out critical regulatory functions. For example, in vertebrates PP4 is important for the proliferation and homeostatic expansion of T cells ([@bib57]), and it positively regulates VDJ recombination during B cell development ([@bib79]). In both yeast and mammals, PP4 functions in the response to genotoxic stress by limiting the duration of DNA damage checkpoints and promoting the recovery from double strand break repair ([@bib52], [@bib48]; [@bib41]; [@bib75]). The *C. elegans* ortholog of the catalytic subunit of the PP4 complex is [PPH-4.1](https://identifiers.org/bioentitylink/WB:WBGene00004085?doi=10.1534/g3.120.401166), and in an *in vitro* expression system it physically interacts with [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) ([@bib42]). During embryogenesis in *C. elegans*, the [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166)/[PPH-4.1](https://identifiers.org/bioentitylink/WB:WBGene00004085?doi=10.1534/g3.120.401166) complex functions to establish asynchrony in the progenitors of different cell lineages by preventing the ATR-Chk1 checkpoint pathway from responding to DNA damage. As a result, ATR-Chk1 controls the timing of cell divisions exclusively in response to developmental cues.

Separate from its role in development, [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) plays a role in lifespan determination in *C. elegans*, as evidenced through functional characterization of [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) in [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* mutants ([@bib88]). For example, the extended lifespan of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* mutants requires [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166). Similar to knockdown of [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166), inhibiting the expression of [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) suppresses the resistance of [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* mutants to oxidative stress, ultraviolet irradiation, and bacterial infection. At the molecular level the increased level of expression of several [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) transcriptional targets in [*daf-2*](https://identifiers.org/bioentitylink/WB:WBGene00000898?doi=10.1534/g3.120.401166)*(*[*e1370*](https://identifiers.org/bioentitylink/WB:WBVar00143949?doi=10.1534/g3.120.401166)*)* animals, including [*sod-3*](https://identifiers.org/bioentitylink/WB:WBGene00004932?doi=10.1534/g3.120.401166), is dependent upon [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166). These data indicate that [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) modulates the function of [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) under conditions in which [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is constitutively activated because of the absence of an inhibitory signal through the IIS pathway. Our work builds upon these observations. We found that [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) contributes to longevity not only in genetic backgrounds where [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) is chronically derepressed but also during normal aging in wildtype animals by facilitating DAF-16-mediated stress resistance. Similar to [*daf-16*](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) loss-of-function mutants, animals subjected to RNAi targeting [*smk-1*](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) show a more pronounced sensitivity to bacterial infection as adults than they do as late larvae ([Figure 8B, C](#fig8){ref-type="fig"}), suggesting that the functional requirement for [SMK-1](https://identifiers.org/bioentitylink/WB:WBGene00018285?doi=10.1534/g3.120.401166) is during adulthood as it is for [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166).

The shift to primarily DAF-16-mediated immunity during adulthood may be a matter of energetic economy. Age-related changes to feeding behavior in *C. elegans* reduce the intake of food ([@bib35]), potentially creating a scarcity of resources to be distributed among multiple layers of host defense. In anticipation of challenges that are yet to be encountered later in life, devoting what resources remain to activating molecules such as [DAF-16](https://identifiers.org/bioentitylink/WB:WBGene00000912?doi=10.1534/g3.120.401166) that confer protection from a broad spectrum of environmental insults would allow the worm to diversify its means of responding to stressors in return for a relatively small energetic investment.
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